metricas
covid
Buscar en
Neurología (English Edition)
Toda la web
Inicio Neurología (English Edition) The clinical characteristics of Hirayama disease in females
Información de la revista
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Visitas
1868
Original article
Open Access
Disponible online el 6 de septiembre de 2022
The clinical characteristics of Hirayama disease in females
Las características clínicas de la enfermedad de Hirayama en mujeres
Visitas
1868
Hongwei Wanga,b,1, Wei Leic,1, Ye Tiana,b, Jianwei Wua,b, Xiaosheng Maa,b, Feizhou Lyua,b,d, Xinlei Xiaa,b, Jingjuan Liangc, Jianyuan Jianga,b, Hongli Wanga,b,
Autor para correspondencia
wanghongli0212@163.com
wanghongli@huashan.org.cn

Corresponding author at: Department of Orthopaedics, Huashan Hospital, Fudan University; Spine Center Fudan University, No. 12 Middle Urumqi Road, Shanghai, 200040, China. Tel.: +86-21-52887126.
a Department of Orthopedics, Huashan Hospital, Fudan University, Shanghai, 200040, China
b Spine Center Fudan University, Shanghai, 200040, China
c Huashan Hospital, Fudan University, Shanghai, 200040, China
d Department of Orthopedics, Shanghai Fifth People’s Hospital, Fudan University, Shanghai 200240, China
Este artículo ha recibido

Under a Creative Commons license
Recibido 28 Febrero 2022. Aceptado 29 Junio 2022
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Figuras (3)
Mostrar másMostrar menos
Abstract
Introduction

To characterize Hirayama disease in female patients, and increase awareness among clinicians regarding the specifics of this disease.

Methods

Baseline data, clinical manifestations, characteristics of cervical-flexion magnetic resonance imaging, and electromyography were collected and compared among females and males with Hirayama disease. In addition, the literature on Hirayama disease in females up to October, 2021 was searched in PubMed and the relevant data were compared with the data from our study.

Results

Twenty female and 40 male patients were included in this study. The average ages of onset and menarche were 14.65 and 12.75 years old. All patients suffered from muscular weakness and atrophy of the upper limb(s), with flattening and/or atrophy of the lower cervical spinal cords in cervical-flexion magnetic resonance imaging, and neurogenic patterns in the atrophic muscles as determined using electromyography. The age of onset in females was about 2 years later than the age of menarche, and the age of onset in females was 2 years earlier than that in males. There were no obvious differences in clinical presentation between males and females.

Discussion

Although females presented with Hirayama disease two years earlier than males, no other clinical differences were observed. Hirayama disease is likely associated with growth and development in puberty, and early identification, regardless of whether patients are male or female, is critical to optimizing prognosis.

Keywords:
Hirayama disease
Female
Pathogenesis
Clinical manifestations
Medical imaging
Electromyography
Abbreviations:
HD
MMA
AHCs
MRI
EMG
LOA
T2WI
MUPs
SD
Resumen
Introducción

Para detallar la enfermedad de Hirayama en pacientes femeninos y promover la conciencia entre los médicos con respecto a los detalles específicos de esta enfermedad.

Metodología

Datos de referencia, manifestaciones clínicas, características de las imágenes de resonancia magnética de flexión cervical y la electromiografía fueron recopilados y comparados entre mujeres y hombres con la enfermedad de Hirayama. Aunado a esto, la literatura sobre la enfermedad de Hirayama en mujeres hasta octubre de 2021 fue revisada en PubMed y la información relevante fue comparada con los datos de nuestro estudio.

Resultado

20 pacientes femeninos y 40 pacientes masculinos fueron incluidos en este estudio. Las edades promedio de inicio y menarquia fueron 14, 65 y 12, 75 años. Todos los pacientes padecían debilidad muscular y atrofia de las extremidades superiores, con aplanamiento y/o atrofia de la médula espinal cervical inferior en imágenes de resonancia magnética de flexión cervical y patrones neurogénicos en los músculos atrofiados como fue determinado usando electromiografía. La edad de inicio en las mujeres fue aproximadamente 2 años más tarde que la edad de la menarquia, y la edad de inicio en las mujeres fue 2 años antes que en los hombres. No hubo diferencias obvias en la presentación clínica entre hombres y mujeres.

Discusión

Aunque las mujeres presentaron la enfermedad de Hirayama dos años antes que los hombres, no se observaron otras diferencias clínicas. Es probable que la enfermedad de Hirayama sea asociada con el crecimiento y desarrollo en la pubertad, y la identificación temprana, independientemente de si los pacientes son hombres o mujeres, es fundamental para optimizar el pronóstico médico.

Palabras clave:
Enfermedad de Hirayama
mujer/femenina
patogénesis
manifestaciones clínicas
imagenología médica
electromiografía
Texto completo
Introduction

Hirayama disease (HD), also known as juvenile benign muscular atrophy of the upper extremities, or monomelic amyotrophy (MMA), is characterized by muscular atrophy in the upper extremities, and predominantly affects unilateral or asymmetric bilateral distal upper limb(s). Hirayama disease typically progresses for 3 to 5 years, then stabilizes. The pathogenesis of Hirayama disease has not been characterized. However, a leading hypothesis is that ischemic injuries in anterior horn cells (AHCs) caused by spinal cord compression on the posterior edge of the vertebral bodies and/or spinal vasospasm during neck flexion because of an imbalance of spinal cord and dura mater during juvenile growth spurts may cause Hirayama disease.1 Therefore, the disease is viewed as self-limiting once growth stops.

Hirayama disease is rare, and the reported incidence is likely inaccurate.2. However, the number of patients with HD has increased in the past two decades. Diagnosis of HD has been more common in Asia, but some cases have been reported in other regions of the world.3,4 Clinical manifestations of HD appeared between ages 15 and 17 in 53.4% of patients.2 In addition, the reported male:female ratio of HD varies as follows: 8.3:1 and 20:1 in Japan; 2.8:1 in India; and 11:1 and 31.6:1 in China.1,2,5,6However, the finding that males were more likely to be diagnosed with HD than females was consistent across these studies.

Most clinicians are not aware of differential presentation of HD between males and females. Therefore, diagnosis of HD might be delayed, or the disease might be misdiagnosed, in females, resulting in poor prognosis. In such cases of delayed or incorrect diagnosis, symptoms such as spastic gait could remain despite proper treatment.7 In recent years, there have been case reports of female patients with HD in many countries and regions,8–10 which suggests that HD may not be as rare in females as previously believed. However, differences between male and female HD cases have not been reported in the literature.

The first two female cases of HD were reported in 2001.11 Since these reports, few case reports focused on female patients with HD have been published, and no clinical research has been performed. Our center is currently the largest center for the diagnosis and treatment of HD, and has taken the lead in formulating international guidelines, proposing new clinical diagnostic criteria and the first clinical classification.12Therefore, we performed a cross-sectional study with the largest sample of female cases in the world using our clinical progression diagnostic criteria, and it provided important information about HD in female and male patients, including clinical manifestations, medical imaging and electrophysiological characteristics. The aim of this study was to elucidate the clinical characteristics of HD in females and to increase awareness of the specifics of this disease in females to aid in early and accurate diagnosis.

MethodsSubjects

Female patients diagnosed with HD between September 2007 and September 2021 in the Department of Orthopedics, Huashan Hospital, Fudan University were included in this study, and two male patients with HD that visited at the same time as the females were also included. The inclusion criteria were as follows: 1) clear clinical diagnosis of HD, as determined by muscular atrophy of an upper limb as the main clinical manifestation, according to the diagnostic criteria,6 2) availability of information regarding clinical manifestations, cervical-flexion magnetic resonance imaging (MRI), and electromyography (EMG), and 3) cross-sectional study. Exclusion criteria were as follows: 1) previous history of cervical spine trauma and surgery, 2) imaging evidence of retrograde degeneration of the cervical spine and obvious skeletal malformations, 3) neoplastic disease, and 4) infectious disease. The project was reviewed and approved by the Institutional Review Board, Huashan Hospital, Fudan University, China, and the requirement for individual consent was waived because the study was observational and the data were anonymized.

Collected data

We recorded baseline data, clinical manifestations, cervical-flexion MRI, and EMG from patients with HD. Baseline data included sex, age of onset, and age of onset of menarche (females only). Clinical manifestations included initial symptoms (including the exact location of atrophy or weakness), affected side(s), deep tendon reflex (characterized as absent, decreased, normal, brisk, and hyperactive), and pathological reflex (presence of Hoffmann sign, Babinski sign, Oppenheim sign, Gordon sign, or Romberg sign). Cervical-flexion MRI data showing anterior-shifting, flattening, and atrophy of the cervical spinal cord, loss of attachment (LOA) between the posterior dural sac and the subjacent lamina (presence of a crescent-shaped high-intensity mass), and high signal intensity at AHCs on T2-weighted imaging (T2WI). Electromyography data showing affected side(s), muscles, and segments, with waves presenting with one of the following: fibrillation potentials, positive sharp waves, increased amplitude of motor unit potentials (MUPs), or pathologic interference patterns.

Literature search

PubMed was searched for articles published in English through September 21, 2021 using “female” AND (“Hirayama disease” OR “juvenile muscular atrophy of distal upper extremity” OR “juvenile amyotrophy of the distal upper extremity” OR “monomelic amyotrophy” OR “benign focal amyotrophy” OR “juvenile asymmetric segmental muscular atrophy” OR “cervical flexion induced myelopathy”) as key words without article type restrictions. Exclusion criteria were as follow: duplication, other diseases, and unavailability of the full text.

The following data were extracted from the literature sources: baseline data, clinical manifestations, cervical-flexion MRI, and EMG. Baseline data included publication date, age of onset, and nationality. Clinical manifestations were the same as those listed in the Collected data section. Cervical-flexion MRI data included LOA and high signal intensity located at AHCs on T2WI. Electromyography data included the affected segments.

Statistical analysis

Normally distributed quantitative variables are presented as the mean and standard deviation (SD), and were analyzed using t tests after excluding missing data. Qualitative and ordinal data were presented as percentages, and were analyzed using χ2 tests, adjusted χ2 tests, and Fisher’s exact tests, as appropriate, after excluding missing data. Statistical analysis was performed using SPSS (Statistical Product and Service Solutions) for Windows (version 26.0; SPSS Inc., Chicago, IL, USA). P < 0.05 was considered statistically significant.

ResultsData of female patients

From September 2007 to September 2021, there were 633 patients diagnosed with HD in our department. Among these, 613 were males and 20 were females, resulting in a male-to-female ratio of 30.65:1. For the 20 female patients, the age of onset ranged from 11 to 21 (14.65 ± 2.250) (Fig. 1), and age of menarche ranged from 10 to 14.5 (12.75 ± 1.278), with the exception of 4 patients for whom the age of menarche was unknown (Table 1).

Figure 1.

The age distribution of female Hirayama disease patients.

(0.18MB).
Table 1.

The detailed information about female Hirayama disease patients.

  Patient 1  Patient 2  Patient 3  Patient 4  Patient 5  Patient 6  Patient 7  Patient 8  Patient 9  Patient 10 
Age of onset/yrs  13  18.5  17.5  12  14  18  13.5  14  11  12.5 
Menarche age/yrs  Unknown  12  Unknown  12  11  13  14.5  14.5  10  14 
Symptom side 
Upper limb deep tendon reflex  Normal  Decreased  Decreased  Normal  Normal  Unknown  Unknown  Unknown  Unknown  Unknown 
Lower limb deep tendon reflex  Normal  Brisk  Normal  Unknown  Brisk  Normal  Normal  Hyperactive  Normal  Normal 
Pathological reflex  Unevoked  Unevoked  Unevoked  Unevoked  Unevoked  Unevoked  Unevoked  B-Hoffmann sign (+)  Unevoked  Unevoked 
LOA  Existing  Existing  Existing  Existing  Existing  Existing  Existing  Existing  Nonexistent  Existing 
Atrophy of cervical spinal cord  Existing  Existing  Existing  Existing  Nonexistent  Nonexistent  Nonexistent  Existing  Nonexistent  Nonexistent 
Flattening of cervical spinal cord  Existing  Existing  Existing  Existing  Existing  Existing  Existing  Existing  Existing  Existing 
T2WI hyperintensity of AHC*  Nonexistent  Nonexistent  Nonexistent  C4-6  Nonexistent  Nonexistent  Nonexistent  C5-7  Nonexistent  Nonexistent 
Affected segments in EMG  C8/T1  C8/T1  C8/T1  C7-C8/T1  C7-C8/T1  C7-C8/T1  C7-C8/T1  C8/T1  C8/T1  C8/T1 
Affected muscles in EMG  ADM; APB; EDC; FDI  Unknown  Unknown  Unknown  APB; EDC; FDI; triceps  APB; EDC; FDI  APB; EDC; FDI  ADM; APB; EDC  ADM; APB; EDC; FDI  ADM; APB; FDI; FPL; triceps 
Affected side(s) in EMG 
Date of outpatient  Aug, 2010  Jul, 2011  Mar, 2013  Jul, 2015  Aug, 2015  Jul, 2016  Dec, 2016  Mar, 2017  Aug, 2017  Jan, 2018 
  Patient 11  Patient 12  Patient 13  Patient 14  Patient 15  Patient 16  Patient 17  Patient 18  Patient 19  Patient 20 
Age of onset/yrs  13  13  16  15  21  17  13  14  14  13 
Menarche age/yrs  13  12.5  Unknown  Unknown  13.5  12.5  12  12  14.5  13 
Symptom side 
Upper limb deep tendon reflex  Hyperactive  Unknown  Normal  Normal  Unknown  Normal  Normal  Normal  Brisk  Unknown 
Lower limb deep tendon reflex  Hyperactive  Hyperactive  Normal  Normal  Normal  Unknown  Brisk  Unknown  Hyperactive  Normal 
Pathological reflex  Unevoked  Unevoked  Unevoked  Unevoked  B-Hoffmann sign (+)  B-Hoffmann sign (+)  B-Hoffmann sign (+)  Unevoked  B-Hoffmann sign (+)  Unevoked 
LOA  Nonexistent  Existing  Existing  Nonexistent  Nonexistent  Nonexistent  Nonexistent  Existing  Existing  Existing 
Atrophy of cervical spinal cord  Nonexistent  Nonexistent  Existing  Existing  Existing  Existing  Existing  Existing  Existing  Existing 
Flattening of cervical spinal cord  Existing  Existing  Existing  Existing  Existing  Existing  Existing  Existing  Existing  Existing 
T2WI hyperintensity of AHC*  Nonexistent  Nonexistent  C5/6  C5/6  C5/6  C4-5  Nonexistent  Nonexistent  C5  Nonexistent 
Affected segments in EMG  C8/T1  C8/T1  C7-8  C8/T1  C7-C8/T1  C7-8  C7-C8/T1  C7-8  C7-C8/T1  C7-C8/T1 
Affected muscles in EMG  ADM; APB; EIP; FDI  EIP; FDI  EDC; EPL  ADM; APB; EPL; FDI; triceps  ADM; APB; EIP; FCR; FCU; FDI; FPL; triceps  ADM; FDI  EDC; FCR; FDI; triceps  EDC; FCR; FDI;  ADM; APB; EDC; FCR; FDI; triceps  ADM; APB; EDC; FCR; FDI 
Affected side(s) in EMG 
Date of outpatient  Aug, 2018  Dec, 2018  Jul, 2019  Aug, 2019  Jun, 2020  Jun, 2020  Sept, 2020  Jan, 2021  Jun, 2021  Sept, 2021 

ADM: abductor digiti minimi; APB: abductor pollicis brevis; AHC: snterior horn cell; B: bilateral; EDC: extensor digitorum communis; EIP: extensor indicis proprius; EMG: electromyography; EPL: extensor pollicis longus; FCR: flexor carpi radialis; FCU: flexor carpi ulnaris; FDI: first dorsal interossei; FPL: flexor pollicis longus; L: left; LOA: loss of attachment; R: right; T2WI: T2-weighted imaging.

*

The level of the vertebral bodies where the hyperintensity is located.

Clinical characteristics

All female patients with HD presented with muscular weakness and atrophy of the upper limb(s), sparing the brachioradialis muscles (oblique atrophy), and cold paralysis. No patients complained of sensory deficits. Seven patients (35.0%) reported symptoms on the left side, 11 (55.0%) reported symptoms on the right side, and 2 (10.0%) reported bilateral symptoms. Eight patients did not have information regarding upper limb deep tendon reflex. In the remaining patients, 8 (66.7%) had normal upper limb deep tendon reflex, 2 (16.7%) showed a decrease, 1 (8.3%) showed a brisk reflex, and 1 (8.3%) showed a hyperactive reflex. Information regarding lower limb deep tendon reflex was unknown for 3 patients, and 10 (58.9%), 3 (17.6%), and 4 (23.5%) had normal, brisk, and hyperactive reflexes, respectively. Finally, Hoffmann sign was elicited in 5 of the 20 female patients with HD (25.0%).

Cervical-flexion MRI

Each female patient underwent a cervical-flexion MRI examination, and the imaging showed flattening and/or atrophy of the lower cervical spinal cords of all of the female patients. Loss of attachment was observed in 14 of the 20 patients (70.0%) (Fig. 2). Furthermore, 7 of 20 (35.0%) showed high signal intensity at AHCs on T2WI.

Figure 2.

A 14-year-old girl whose menarche age was 13 complained of difficulty in extending fingers of the right hand (A and B). Loss of attachment was found in cervical-flexion magnetic resonance imaging (C and D).

(0.58MB).
Electromyography

Electromyography data was collected for each of the 20 female patients, all of whom showed neurogenic patterns in the atrophic muscles. Ten of 20 patients (50.0%) showed neurogenic changes in the bilateral sides in EMG, but 8 (40.0%) only complained of unilateral symptoms. In the other 2 patients with bilateral symptoms, the side with more severe symptoms was consistent with the side with more severe damage in EMG. The affected cervical spinal cord segments in EMG were C7-8/T1. The numbers of patients affected at C7, C8, and T1 were 9 (45.0%), 20 (100%), and 17 (85.0%), respectively. Finally, 3 patients did not have detailed information on the affected muscles. In the remaining 17 patients, neurogenic changes were observed in the following 10 muscles: first dorsal interossei in 15 patients (88.2%); abductor pollicis brevis in 12 (70.6%); extensor digitorum communis in 11 (64.7%); abductor digiti minimi in 10 (58.8%); triceps in 6 (35.3%); flexor carpi radialis in 5 (29.4%); extensor indicis proprius in 3 (17.6%); extensor pollicis longus in 2 (11.8%); flexor pollicis longus in 2 (11.8%); and flexor carpi ulnaris in 1 (5.9%).

Comparison of male and female cases

We also collected data from male patients with HD, and compared females to males at a 1:2 ratio (Table 2). There was a significant difference in age of onset between males and females (P = .005; Fig. 1). In contrast, there were no significant differences in symptom side(s) (P = .799), upper limb tendon reflex (P = .585), lower limb deep tendon reflex (P = .917), pathological reflex (P = .319), LOA (P = .061), hyperintensity of AHC on T2WI (P = .418), or affected segments in EMG (P = .708) (Table 3).

Table 2.

Comparison of male and female Hirayama disease patients.

Female  Male  P 
Clinical manifestations     
Age of onset/yrs (M ± SD)14.65 ± 2.550  16.68 ± 2.526  .005 
PMenarche age/yrs (M ± SD)12.75 ± 1.278  —   
Symptom sideLeft  7 (35%)  17 (42.5%)  .799
Right  11 (55%)  18 (45%) 
Bilateral  2 (10%)  5 (12.5%) 
Ulnar side19/19  37/38   
Upper limb deep tendon reflexNormal  8 (66.7%)  20 (69.0%)  .585
Decreased  2 (16.7%)  5 (17.2%) 
Active  1 (8.3%)  4 (13.8%) 
Hyperactive  1 (8.3%) 
Unknown  11   
Lower limb deep tendon reflexNormal  10 (58.9%)  23 (63.9%)  .917
Decreased 
Active  3 (17.6%)  5 (13.9%) 
Hyperactive  4 (23.5%)  8 (22.2%) 
Unknown   
Pathological reflex (+)5/20 (25%)  5/40 (12.5%)  .319 
Neck-flexion MRI     
LOA14/20 (70%)  36/39 (92.3%)  .061 
T2WI hyperintensity of AHC7/20 (35%)  10/40 (25%)  .418 
EMG     
Affected segmentsC7-C8/T1  C5-C8/T1   
Affected side(s)Left  4 (20%)  9 (22.5%)  .708
Right  6 (30%)  8 (20%) 
Bilateral  10 (50%)  23 (57.5%) 

AHC: Anterior horn cell; EMG: Electromyography; LOA: Loss of attachment; MRI: Magnetic resonance imaging; M ± SD: Mean ± Standard deviation; T2WI: T2-weighted imaging.

Table 3.

Review of the literatures of females suffered from Hirayama Disease.

Reference  11  11  22  13  13  21  19  19  24  20  16  16 
Age of onset/yrs  13  15  34  19  36  14  15  13  np  19  17  14 
Symptom side 
Affected muscles  Distal upper extremity  Distal upper extremity  APB; FPL; FDI; FCR; FCU; EIP  EDC; APB; FDI; forearm  APB; FDI; thenar  FDI; hypothenar  np  np  Distal upper extremity  Hand and forearm  Hand and forearm  Hand and forearm 
Upper limb deep tendon reflex  Normal  Normal  Decreased  Brisk  np  Normal  np  np  np  Normal  np  np 
Lower limb deep tendon reflex  Normal  Normal  Normal  Normal  np  Normal  np  np  np  Normal  Brisk  Brisk 
Pathological reflex  Unevoked  Unevoked  np  Unevoked  np  Unevoked  np  np  Unevoked  Unevoked  Unevoked  Unevoked 
LOA  Existing  Existing  np  np  Nonexistent  Existing  np  np  Existing  Existing  np  np 
Hyperintensity of AHC in T2WI  Nonexistent  Nonexistent  np  Nonexistent  Nonexistent  Existing  np  np  Existing  Nonexistent  np  np 
Affected segments in EMG  np  np  np  np  np  np  np  np  C7-C8/T1  C7-C8/T1  C7-C8/T1*  C7-C8/T1* 
Nationality  Japan  Japan  America  Greek  Greek  Japan  America  America  Germany  Japan  Germany  Germany 
Year of publication  2001  2001  2008  2009  2009  2010  2011  2011  2011  2012  2013  2013 
Reference  18  18  15  14  17  23  23  10 
Age of onset/yrs  16.5  12.5  10.5  17  12  15  16  17  17.5  18  28  28 
Symptom side  Unilateral  Unknown  Unknown  Unknown 
Affected muscles  Distal upper extremity  Distal upper extremity  Thenar; hypothenar; intrinsic hand muscles  Hand  Intrinsic hand muscles; forearm  Distal upper extremity  np  np  FDI; ADM  np  Thenar; hypothenar; intrinsic hand muscles  Hand and the dorsal face of the forearm 
Upper limb deep tendon reflex  Normal  Decreased  Normal  np  Decreased  Decreased  np  np  Normal  np  Decreased  Absent radial stylus 
Lower limb deep tendon reflex  Normal  np  Normal  np  Hyper-active  Brisk  np  np  Normal  np  Brisk  Absent pronator cubit 
Pathological reflex  Unevoked  Unevoked  Unevoked  np  Romberg and Babinski(+)  np  np  np  np  np  Hoffmann sign (+)  Unevoked 
LOA  np  np  Nonexistent  Nonexistent  Existing  Existing  Existing  Existing  Existing  np  Existing  Nonexistent 
Hyperintensity of AHC in T2WI  np  np  Existing  Nonexistent  Existing  Existing  Nonexistent  Existing  Nonexistent  np  Existing  Nonexistent 
Affected segments in EMG  np  np  C7-C8/T1  np  C5-C8/T1  np  np  np  C7-C8/T1  C7-C8/T1  np  C7-C8/T1 
Nationality  Austria  Austria  Austria  Turkey  Japan  Japan  Russia  Russia  India  India  China  Albnia 
Year of publication  2013  2013  2017  2017  2017  2019  2019  2019  2019  2019  2019  2020 

ADM: Abductor digiti minimi;APB: Abductor pollicis brevis; AHC: Anterior horn cell; B: Bilateral; EDC: Extensor digitorum communis; EIP: Extensor indicis proprius; EMG: Electromyography; FCR: Flexor carpi radialis; FCU: Flexor carpi ulnaris; FDI: First dorsal interossei; FPL: Flexor pollicis longus; L: Left; LOA: Loss of attachment; np: not applicated; R: Right; T2WI: T2-weighted imaging.

*

Interpretation based on the EMG data provided.

Literature review

We reviewed literature regarding females with HD with detailed information published in English through September 2021. Seventeen7–11,13–24 studies reported 24 female cases of HD from Asia, Europe, America, and Oceania. The detailed information from these studies is summarized in Table 3.

The median age of onset was 16.5 years of age, the range was not normally distributed, and after excluding 4 outliers and 1 patient with unknown age of onset the ages ranged from 10.5 to 19 (15.32 ± 2.43). These results were similar to those in our study (P = .410). The clinical manifestations reported were wasting and weakness of the distal upper limb(s), which was also consistent with our study. Four cases did not indicate which side was affected, 2 of 20 (10.0%) reported that the left side was affected, 8 (40.0%) reported that the right side was affected, and 10 (50.0%) reported bilateral symptoms in the upper extremities. These results were different from those in our study (P = .014). Upper limb deep tendon reflex was not reported for 10 patients, and 7 of 14 patients (50.0%) showed a normal reflex, 6 patients (42.9%) showed decreased or absent reflex, 1 (7.1%) showed brisk reflex, and no patients showed a hyperactive reflex. Lower limb deep tendon reflex was not reported in 9 patients, and 9 (65.0%), 1 (6.7%), 4 (26.6%), and 1 (6.7%) of 15 patients showed normal, decreased or absent, brisk, and hyperactive reflexes, respectively. Furthermore, pathological reflexes were observed in 2 of 14 patients (14.3%), and information was not provided for 10 patients. There were no significant differences in upper limb deep tendon reflex (P = .534), lower limb deep tendon reflex (P = .497), or pathological reflex (P = .676) between these previous studies and our study.

In cervical-flexion MRI, LOA was observed in 11 of 15 patients (73.3%), and information was not available for 9 patients. High signal intensity at AHCs on T2WI was observed in 7 of 16 patients (43.75%), and information was not available for 8 patients. There were no significant differences in these two parameters between previous studies and our study (P = 1.000 and P = .734). Finally, fifteen patients did not have EMG data. In the remaining 9 patients, the numbers of patients with affected cervical spinal segments at C5, C6, C7, C8, and T1 were 1 (11.1%), 1 (11.1%), 9 (100%), 9 (100%), and 9 (100%). Only the number of patients with C7 affected was significantly different from ours (P = .027), whilst the others were similar (C5/C6: P = .310, C8: P = 1.000, and T1: P = .532).

Discussion

Hirayama disease was first reported in 12 cases by Hirayama25 in 1959, and was initially called juvenile muscular atrophy of unilateral upper extremity. Most patients with HD were juvenile males from Asia who presented with muscular weakness and atrophy of the distal unilateral upper limb, without sensory deficits. The disease was observed to be self-limiting after a progression of 3-5 years. The clinical characteristics in female patients with HD are similar to those in males, but age of onset in females is 2 years earlier than in males. No series of reports has previously characterized HD in females. Our study was a cross-sectional study with the largest number of reported cases of females with HD.

The average age of onset of HD in females is 2 years later than the average age of menarche. Menstruation marks the beginning of puberty, during which growth accelerates, which may correlate with onset of HD in female patients. Cross-innervation of spinal nerve segments may also explain why the onset of HD is approximately 2 years after menarche.

Later age of onset of HD in males compared to females requires further study. On average, adult females are shorter than males, which indicates that growth may occur at a slower overall rate in females. This may also explain why the incidence in females is lower than that in males. According to Li and Ji et al.26, girls grow fastest from 9 to 12 years old, while boys grow fastest from 11 to 14 years old. Therefore, Chinese girls experience fastest growth approximately two years earlier than Chinese boys. In addition, a study by Ding et al.27 showed the heights of 60 patients with HD increased by 7.1 ± 1.8 cm in the year prior to disease onset. This finding suggested that the onset of HD might correlate with growth in puberty, and further supported the hypothesis that cervical spinal cord compression was an underlying cause of HD for the disproportionate lengths of the spinal cord and canal.28–31 However, the vast majority of adolescents who undergo growth spurts do not suffer from HD. Therefore, pathogenesis of HD is likely more complex than spinal compression during growth, such as immune factors,32 dysplasia of the spinal venous plexus,33 and structural abnormalities of the spinal ligaments.34 The results of our study were different from those in a nationwide survey of HD in Japan.2 The onset of HD was earlier (mean 17.6 years) in males than that in females (mean 19.3 years), but the difference in age of onset was not significantly different between males and females. They concluded that these sex-related differences in age of onset might have been due to differential effects of sex hormones on motor neurons.

There were no significant differences between males and females in symptom side(s), upper limb tendon reflex, lower limb deep tendon reflex, pathological reflex, “sand-watch’’ spinal cord,35 LOA, hyperintensity of AHC on T2WI, or affected segments in EMG. Therefore, there were no differences in clinical presentation between males and females, and all patients met the same diagnostic criteria.

In our study, both sides of the body were affected equally, which was not consistent with previous studies.2 A possible reason for unilateral involvement to be common may be due to asymmetric compression of the cervical spinal cord due to unequal left-to-right distribution of posterior epidural ligaments between the ligamentum flavum and the posterior dura.36 What needs attention is that it is common for symptoms affected both sides; the number of patients suffering from bilateral symptoms were more than stereotype in clinicians’ mind possibly. Furthermore, the numbers of patients with unilateral or bilateral symptoms may not be reflected in EMG results. The number of patients with bilateral changes in EMG was greater than the number of patients who complained of unilateral weakness and atrophy (Fig. 3). This discrepancy may indicate that changes in EMG might precede onset of clinical symptoms of HD. Therefore, failure to intervene early in patients with changes in EMG only might result in increased risk of bilateral weakness and atrophy, and poorer prognosis. Although HD is considered a self-limiting disease, early intervention is critical to avoiding poor prognosis.37 and delays in diagnosis or misdiagnosis can directly result in greater severity of HD.38

Figure 3.

The affected side(s) of female Hirayama disease patients in clinical manifestations and electromyography.

(0.14MB).

Prior to our study, only 24 cases of females with HD had been described in publications. In these publications, the results were similar to those in our study. The differences were that more patients presented with bilateral atrophy and more patients showed C7 injury in EMG in literature review. This difference may have indicated that symptoms had progressed to collateral side and adjacent segment in cervical spinal cord due to later diagnosis. Therefore, the characteristics of females with HD were similar in Asia as in the rest of the world, which further indicated that HD was not a disease only found in Asia. Furthermore, the low rate of diagnosis might be a result of lack of awareness of HD.39 It is possible that the incidence of HD has been underestimated,6,40 and HD is likely not limited to Asia.3

There were some limitations to our study. First, this was a single-center clinical study, which limited generalization of our conclusions. Furthermore, small sample size may have contributed to bias. However, our study described the largest sample of females with HD to date, which indicates that our study may have suffered from less bias than other previous studies. Finally, the cross-sectional nature of our study did not allow for determination of a causal relationship. However, because growth during adolescence occurs in one direction and occurs in every individual, we were able to make strong estimates of the causal relationship between growth and onset of HD.

The clinical characteristics of HD, including clinical manifestations, cervical-flexion MRI, and EMG were similar among all patients. The major difference observed in our study was that female patients experienced onset of HD 2 years earlier than male patients. Hirayama disease likely results from compression of the lower cervical spinal cord caused by abnormal development of the cervical spinal cord during adolescence. When adolescent females aged 13-18, particularly 2 years after menarche, present with unilateral or asymmetrical localized muscle atrophy of the upper limb without cranial nerve and lower extremity muscle involvement, clinicians should consider the possibility of HD and perform MRI in the flexed neck position and EMG to allow for early diagnosis and early intervention. A diagnosis should be made as early as possible, regardless of whether the patient is male or female, to improve prognosis and to limit disabilities.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Study funding

Clinical Research Plan of SHDC (No.SHDC2020CR4030), Clinical Technology Innovation Project of SHDC (No. SHDC12019X26),National Natural Science Foundation of China (No.82072488) and AO Spine National Research Grant 2020 [No. AOSCN(R)2020-9]

Author contributions

HW Wang, W Lei and HL Wang designed research. HW Wang, W Lei contributed unpublished data and performed research. Y Tian, JW Wu and HW Wang did the literature search. HW Wang analyzed data, and wrote original draft. XL Xia, XS Ma, FZ Lyu, JY Jiang, and HL Wang were responsible for supervision.

References
[1]
K. Hirayama.
Juvenile muscular atrophy of distal upper extremity (Hirayama disease).
Intern Med (Tokyo, Japan), 39 (2000), pp. 283-290
[2]
K. Tashiro, S. Kikuchi, Y. Itoyama, et al.
Nationwide survey of juvenile muscular atrophy of distal upper extremity (Hirayama disease) in Japan.
Amyotroph Lateral Scler, 7 (2006), pp. 38-45
[3]
M. Correia de Sa, H. Costa, S. Castro, M. Vila Real.
A Portuguese case of Hirayama disease.
[4]
B. Elsheikh, J.T. Kissel, G. Christoforidis, et al.
Spinal angiography and epidural venography in juvenile muscular atrophy of the distal arm "Hirayama disease".
Muscle Nerve, 40 (2009), pp. 206-212
[5]
O. Hashimoto, M. Asada, M. Ohta, Y. Kuroiwa.
Clinical observations of juvenile nonprogressive muscular atrophy localized in hand and forearm.
J Neurol, 211 (1976), pp. 105-110
[6]
H. Wang, C. Zheng, X. Jin, et al.
The Huashan diagnostic criteria and clinical classification of Hirayama disease.
Chin J Orthop (Chin), 39 (2019), pp. 458-465
[7]
T. Fujimori, A. Tamura, T. Miwa, M. Iwasaki, T. Oda.
Severe cervical flexion myelopathy with long tract signs: a case report and a review of literature.
Spinal Cord Ser Cases, 3 (2017), pp. 17016
[8]
A. Antonioni, M. Fonderico, E. Granieri.
Hirayama disease: a case of an Albanian woman clinically stabilized without surgery.
Front Neurol, 11 (2020), pp. 183
[9]
S.V. Khadilkar, M.B. Singla, P. Ohja, S. Jaggi.
Evaluation of two female patients of Hirayama disease supports the longer neck hypothesis.
J Neurol Sci, 399 (2019), pp. 167-168
[10]
W. Wu, S. Wang, J. Lin.
A 34-year-old female patient with Hirayama disease complicated by severe spinal cord injury.
World Neurosurg, 130 (2019), pp. 84-88
[11]
J. Kira, H. Ochi.
Juvenile muscular atrophy of the distal upper limb (Hirayama disease) associated with atopy.
J Neurol Neurosurg Psychiatry, 70 (2001), pp. 798-801
[12]
H. Wang, Y. Tian, J. Wu, et al.
Update on the pathogenesis, clinical diagnosis, and treatment of Hirayama disease.
[13]
E. Andreadou, K. Christodoulou, P. Manta, et al.
Familial asymmetric distal upper limb amyotrophy (Hirayama disease): report of a Greek family.
Neurologist, 15 (2009), pp. 156-160
[14]
H. Ay.
Hirayama disease (monomelic amyotrophy) clinically confused for carpal tunnel syndrome.
Neuropsychiatr Dis Treat, 13 (2017), pp. 1385-1388
[15]
M. Baumann, J. Finsterer, E.R. Gizewski, W.N. Loscher.
Early-onset Hirayama disease in a female.
SAGE Open Med Case Rep, 5 (2017),
[16]
K. Boelmans, J. Kaufmann, S. Schmelzer, et al.
Hirayama disease is a pure spinal motor neuron disorder—a combined DTI and transcranial magnetic stimulation study.
J Neurol, 260 (2013), pp. 540-548
[17]
S. Dohzono, H. Toyoda, A. Tamura, K. Hayashi, H. Terai, H. Nakamura.
Surgical treatment of a patient with prolonged exacerbation of Hirayama disease.
Spine Surg Relat Res, 3 (2019), pp. 95-97
[18]
J. Finsterer, W. Loscher, J. Wanschitz, M. Baumann, S. Quasthoff, W. Grisold.
Hirayama disease in Austria.
Joint Bone Spine, 80 (2013), pp. 503-507
[19]
P.S. Ghosh, M. Moodley, N.R. Friedman, A.D. Rothner, D. Ghosh.
Hirayama disease in children from North America.
J Child Neurol, 26 (2011), pp. 1542-1547
[20]
M. Hashimoto, M. Yoshioka, Y. Sakimoto, M. Suzuki.
A 20-year-old female with Hirayama disease complicated with dysplasia of the cervical vertebrae and degeneration of intervertebral discs.
[21]
T. Hosokawa, M. Fujieda, H. Wakiguchi, Y. Oosaki.
Pediatric Hirayama disease.
Pediatr Neurol, 43 (2010), pp. 151-153
[22]
D.R. Patel, L. Knepper, H.R. Jones Jr..
Late-onset monomelic amyotrophy in a Caucasian woman.
Muscle Nerve, 37 (2008), pp. 115-119
[23]
A. Rosliakova, I. Zakroyshchikova, I. Bakulin, et al.
Hirayama disease: analysis of cases in Russia.
Neurol Sci, 40 (2019), pp. 105-112
[24]
F. Weber, U.M. Mauer.
Flexion myelopathy: Hirayama’s syndrome.
J Neurol, 259 (2012), pp. 567-568
[25]
K. Hirayama, Y. Toyokura, T. Tsubaki.
Juvenile muscular atrophy of unilateral upper extremity: a new clinical entity.
Psychiatry Neurol Jpn, 61 (1959), pp. 2190-2198
[26]
H.J.C. Li, X. Zong, Y. Zhang.
Height and weight standardized growth charts for Chinese children and adolescents aged 1 to 18 years.
Chin J Pediatr, 47 (2009), pp. 487-492
[27]
Y.R.D. Ding, X. Wang.
To evaluate the cervical spine curvature and growth rate for studying the pathogenesis of Hirayama disease in adolescents.
Chin J Intern Med, 54 (2015), pp. 721-724
[28]
M. Kohno, H. Takahashi, A. Yagishita, H. Tanabe.
“disproportion theory” of the cervical spine and spinal cord in patients with juvenile cervical flexion myelopathy - extension movements of the head and spine upon the spinal cord and nerve roots.
Surg Neurol, (1998), pp. 50
[29]
H. Ito, K. Takai, M. Taniguchi.
Cervical duraplasty with tenting sutures via laminoplasty for cervical flexion myelopathy in patients with Hirayama disease: successful decompression of a "tight dural canal in flexion" without spinal fusion.
J Neurosurg Spine, 21 (2014), pp. 743-752
[30]
C. Hou, H. Han, X. Yang, et al.
How does the neck flexion affect the cervical MRI features of Hirayama disease?.
Neurol Sci, 33 (2012), pp. 1101-1105
[31]
Y. Fujimoto, S. Oka, N. Tanaka, K. Nishikawa, H. Kawagoe, I. Baba.
Pathophysiology and treatment for cervical flexion myelopathy.
Eur Spine J, 11 (2002), pp. 276-285
[32]
S. Ito, S. Kuwabara, T. Fukutake, Y. Tokumaru, T. Hattori.
HyperIgEaemia in patients with juvenile muscular atrophy of the distal upper extremity (Hirayama disease).
J Neurol Neurosurg Psychiatry, 76 (2005), pp. 132-134
[33]
E.F. Ciceri, L. Chiapparini, A. Erbetta, et al.
Angiographically proven cervical venous engorgement: a possible concurrent cause in the pathophysiology of Hirayama’s myelopathy.
Neurol Sci, 31 (2010), pp. 845-848
[34]
Y. Yoshiyama, Y. Tokumaru, K. Arai.
Flexion-induced cervical myelopathy associated with fewer elastic fibers and thickening in the posterior dura mater.
J Neurol, 257 (2009), pp. 149-151
[35]
P. Bede, R. Walsh, A.J. Fagan, O. Hardiman.
"Sand-watch" spinal cord: a case of inferior cervical spinal cord atrophy.
J Neurol, 261 (2014), pp. 235-237
[36]
K. Shinomiya, J. Dawson, D. Spengler, P. Konrad, B. Blumenkopf.
An analysis of the posterior epidural ligament role on the cervical spinal cord.
[37]
B. Zhou, L. Chen, D. Fan, D. Zhou.
Clinical features of Hirayama disease in mainland China.
Amyotroph Lateral Scler, 11 (2010), pp. 133-139
[38]
K. Sakai, K. Ono, Y. Okamoto, H. Murakami, M. Yamada.
Cervical flexion myelopathy in a patient showing apparent long tract signs: a severe form of Hirayama disease.
Joint Bone Spine, 78 (2011), pp. 316-318
[39]
J. Tavee, K. Levin.
Myelopathy due to degenerative and structural spine diseases.
Continuum (Minneapolis, Minn), 21 (2015), pp. 52-66
[40]
R. Verma, R. Lalla, T.B. Patil, A. Gupta.
Hirayama disease: a frequently undiagnosed condition with simple inexpensive treatment.

Shared the first authorship.

Descargar PDF
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos